ES2162520T3 - Medicamentos basados en hiperforina y/o extractos de hiperforina. - Google Patents

Medicamentos basados en hiperforina y/o extractos de hiperforina.

Info

Publication number
ES2162520T3
ES2162520T3 ES99932474T ES99932474T ES2162520T3 ES 2162520 T3 ES2162520 T3 ES 2162520T3 ES 99932474 T ES99932474 T ES 99932474T ES 99932474 T ES99932474 T ES 99932474T ES 2162520 T3 ES2162520 T3 ES 2162520T3
Authority
ES
Spain
Prior art keywords
hyperforine
extracts
hyperforin
medications based
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99932474T
Other languages
English (en)
Inventor
Shyam Sunder Chatterjee
Clemens Erdelmeier
Michael Noldner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Willmar Schwabe GmbH and Co KG
Original Assignee
Dr Willmar Schwabe GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe GmbH and Co KG filed Critical Dr Willmar Schwabe GmbH and Co KG
Application granted granted Critical
Publication of ES2162520T3 publication Critical patent/ES2162520T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Utilización de hiperforina y extractos con contenido de hiperforina de Hypericum perforatum L. (corazoncillo) para la producción de un medicamento para el tratamiento y la profilaxis de enfermedades demenciales, principalmente la enfermedad de Alzheimer, la demencia vascular y formas mixtas de demencia.
ES99932474T 1998-02-13 1999-02-04 Medicamentos basados en hiperforina y/o extractos de hiperforina. Expired - Lifetime ES2162520T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19805946 1998-02-13

Publications (1)

Publication Number Publication Date
ES2162520T3 true ES2162520T3 (es) 2001-12-16

Family

ID=7857638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99932474T Expired - Lifetime ES2162520T3 (es) 1998-02-13 1999-02-04 Medicamentos basados en hiperforina y/o extractos de hiperforina.

Country Status (9)

Country Link
US (1) US6322824B1 (es)
EP (1) EP1054682B1 (es)
JP (1) JP2002539070A (es)
AT (1) ATE204759T1 (es)
AU (1) AU754679B2 (es)
CA (1) CA2320154A1 (es)
DE (1) DE59900222D1 (es)
ES (1) ES2162520T3 (es)
WO (1) WO1999040905A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2320091A1 (en) * 1998-02-13 1999-08-19 Dr. Willmar Schwabe Gmbh & Co. Stable hyperforin salts, methods of manufacturing them, and their use for the treatment of alzheimer's disease
EP1126882B1 (de) * 1998-11-04 2009-12-30 Dr. Willmar Schwabe GmbH & Co. KG Stabile zubereitungen mit hyperforin
US7205008B2 (en) * 2000-03-15 2007-04-17 Proteotech, Inc. Methods of treating Alzheimer's disease and other amyloidoses using Hypericum perforatum and derivatives thereof
DE10131641A1 (de) * 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
DE10213571A1 (de) * 2002-03-26 2003-10-23 Lichtwer Pharma Ag Pflanzenextrakte und deren Anwendung
ITMI20020871A1 (it) * 2002-04-23 2003-10-23 Indena Spa Derivati alogenati dell'iperforina loro uso e formulazioni che li contengono
ITMI20020872A1 (it) 2002-04-23 2003-10-23 Indena Spa Derivati dell'iperforina loro uso e formulazioni che li contengono
WO2005095983A1 (en) * 2004-03-04 2005-10-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with protein kinase c, gamma (prkcg)
DE202009018261U1 (de) 2009-12-23 2011-11-09 Finzelberg Gmbh & Co. Kg Johanniskrautextrakte zur Behandlung von neurodegenerativen Erkrankungen
CN102665743B (zh) 2009-12-23 2014-12-17 芬策尔贝格有限两合公司 用于治疗神经退行性疾病的植物提取物
PL2608798T5 (pl) 2010-08-27 2019-04-30 Finzelberg Gmbh & Co Kg Wyciągi roślinne z gojnika oraz ich zastosowanie do zwiększenia sprawności poznawczej

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0733332B2 (ja) * 1985-11-19 1995-04-12 富山化学工業株式会社 痴呆症状改善・治療剤
JPH04210642A (ja) * 1990-12-10 1992-07-31 Kao Corp 抗痴呆剤
DE4239959A1 (de) 1992-11-27 1994-06-01 Schwabe Willmar Gmbh & Co Johanniskraut-Trockenextrakt, Verfahren zu seiner Herstellung und seine Verwendung
DE19619512C5 (de) * 1995-09-29 2006-04-20 Dr. Willmar Schwabe Gmbh & Co. Kg Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen
DE19646977A1 (de) 1995-09-29 1998-01-15 Schwabe Willmar Gmbh & Co Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
WO2000057707A1 (en) * 1999-03-15 2000-10-05 Proteotech, Inc. Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof
US6159986A (en) * 1999-11-02 2000-12-12 Altman; David A. Compounds and therapy for resisting memory loss in humans

Also Published As

Publication number Publication date
CA2320154A1 (en) 1999-08-19
WO1999040905A3 (de) 1999-09-23
WO1999040905A2 (de) 1999-08-19
JP2002539070A (ja) 2002-11-19
US6322824B1 (en) 2001-11-27
DE59900222D1 (de) 2001-10-04
AU3252699A (en) 1999-08-30
EP1054682A2 (de) 2000-11-29
ATE204759T1 (de) 2001-09-15
AU754679B2 (en) 2002-11-21
EP1054682B1 (de) 2001-08-29

Similar Documents

Publication Publication Date Title
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
BR9713400A (pt) Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese.
HUP9903906A2 (hu) Kelátképző clioquinol felhasználása Alzheimer-kór kezelésére alkalmas gyógyszerkészítmények előállításánál
WO1997013489A3 (de) Stabiler extrakt aus hypericum perforatum l., verfahren zu seiner herstellung und pharmazeutische zubereitungen
NZ251320A (en) Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
YU1097A (sh) 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni
DOP2002000429A (es) Imidazotriazinas
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
ES2192839T3 (es) Timosina beta 4 oxidada.
HUP0102546A2 (hu) Szorongásos állapot vagy depresszió következtében kialakult idegi és viselkedési változások megelőzésére és/vagy kezelésére alkalmas neuroprotektív készítmények
BR9807937A (pt) Extrato estável de hypericum perforatum l. (erva-de-são joão), processo para a preparação do mesmo, e, composição farmacêutica
NO902280D0 (no) Ny poroes farmasoeytisk form og fremstilling derav.
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
ES2162520T3 (es) Medicamentos basados en hiperforina y/o extractos de hiperforina.
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
DE60115054D1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
DE59707550D1 (de) Pharmazeutische Zubereitung, die 2-Phenyl-1,2-Benzoisoelenazol-3(2H)-one enthält, für die Behandlung der Alzheimer-Krankheit
ES2193765T3 (es) Pomada o crema de hiperforina.
WO2000072833A3 (de) Pharmazeutische zubereitungen zur hemmung von spimgomyelinase
BRPI0418749A (pt) composição herbal
HUP0301831A2 (hu) Gepiron bioaktív metabolitjainak alkalmazása pszichológiai rendellenességek kezelésére
ATE404519T1 (de) Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen
SV2002000626A (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso ref. lea 34750-sv
DK0707477T3 (da) Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1054682

Country of ref document: ES